- Home
- UGRO vs TLPH Comparison
UGRO vs TLPH Comparison
Compare UGRO & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- TLPH
- Stock Information
- Founded
- UGRO 2014
- TLPH 2005
- Country
- UGRO United States
- TLPH United States
- Employees
- UGRO N/A
- TLPH N/A
- Industry
- UGRO Industrial Specialties
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- TLPH Health Care
- Exchange
- UGRO Nasdaq
- TLPH Nasdaq
- Market Cap
- UGRO 18.0M
- TLPH 12.7M
- IPO Year
- UGRO N/A
- TLPH 2011
- Fundamental
- Price
- UGRO $1.07
- TLPH $0.64
- Analyst Decision
- UGRO Strong Buy
- TLPH Strong Buy
- Analyst Count
- UGRO 2
- TLPH 2
- Target Price
- UGRO $5.63
- TLPH $4.50
- AVG Volume (30 Days)
- UGRO 55.7K
- TLPH 96.2K
- Earning Date
- UGRO 12-27-2024
- TLPH 11-13-2024
- Dividend Yield
- UGRO N/A
- TLPH N/A
- EPS Growth
- UGRO N/A
- TLPH N/A
- EPS
- UGRO N/A
- TLPH N/A
- Revenue
- UGRO $70,320,066.00
- TLPH $281,000.00
- Revenue This Year
- UGRO $14.76
- TLPH N/A
- Revenue Next Year
- UGRO $21.29
- TLPH N/A
- P/E Ratio
- UGRO N/A
- TLPH N/A
- Revenue Growth
- UGRO 12.08
- TLPH N/A
- 52 Week Low
- UGRO $0.93
- TLPH $0.60
- 52 Week High
- UGRO $2.84
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- UGRO 33.37
- TLPH 39.75
- Support Level
- UGRO $1.17
- TLPH $0.60
- Resistance Level
- UGRO $1.19
- TLPH $0.76
- Average True Range (ATR)
- UGRO 0.11
- TLPH 0.07
- MACD
- UGRO -0.02
- TLPH -0.00
- Stochastic Oscillator
- UGRO 24.78
- TLPH 17.65
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.